Accuracy and Reliability in Differentiating Retinal Arteries and Veins Using Widefield En Face OCT Angiography.
diabetic retinopathy
image analysis
optical coherence tomography
retina
retinal vasculature
Journal
Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
received:
24
01
2019
accepted:
07
04
2019
entrez:
19
7
2019
pubmed:
19
7
2019
medline:
19
7
2019
Statut:
epublish
Résumé
To evaluate the accuracy and reliability in differentiating retinal arteries from veins using widefield optical coherence tomography angiography (OCTA). Ten healthy eyes and 12 eyes from diabetic patients were included. Foveal-centered swept-source OCTA images (12 × 12 mm) were obtained using the PLEX Elite 9000. Vessels were graded as arteries or veins by two independent, masked readers. Arteriovenous crossings were also evaluated in healthy eyes. The vessel identification gold standard was defined using color fundus photographs (CFP) for normal eyes and both CFP and fluorescein angiography for diabetic eyes. Grading accuracy was compared to the gold standard and reliability between readers assessed. The study evaluated 538 vessels (119 first order, 110 second, 309 third) in healthy eyes and 645 vessels (184 first order, 159 second, 302 third). In healthy eyes, the average accuracies identifying all, first-, second-, and third-order vessels were 98.61%, 99.16%, 100%, and 98.06%, respectively. Cohen's κ between graders in all vessels was 0.948. In diabetic eyes, the average accuracies identifying vessels were 96.90%, 99.46%, 97.77%, and 94.85%, respectively. Cohen's κ between graders for all vessels was 0.888. For crossing identification, the average accuracy and Cohen's κ were low (60.71% and 0.659, respectively). En face OCTA allows for accurate and reliable artery and vein identification; for small branches and crossings, identification by en face OCTA alone may be less accurate and reliable. Arteries and veins can be differentiated on OCTA, assisting in clinically identifying pathology as arterial or venous side.
Identifiants
pubmed: 31316862
doi: 10.1167/tvst.8.3.60
pii: TVST-19-1374R1
pmc: PMC6602142
doi:
Types de publication
Journal Article
Langues
eng
Pagination
60Commentaires et corrections
Type : ErratumIn
Références
Am J Epidemiol. 1999 Aug 1;150(3):263-70
pubmed: 10430230
Ophthalmology. 1999 Dec;106(12):2269-80
pubmed: 10599656
Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1644-50
pubmed: 10845884
Can J Ophthalmol. 2002 Apr;37(3):182-3
pubmed: 12083478
Br J Ophthalmol. 1953 May;37(5):282-92
pubmed: 13042023
Ophthalmology. 2003 Sep;110(9):1677-82
pubmed: 13129861
Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4960-7
pubmed: 14578423
Hypertension. 2006 Feb;47(2):189-94
pubmed: 16380526
Diabetes. 2006 Feb;55(2):506-10
pubmed: 16443787
Microcirculation. 2007 Jan;14(1):25-38
pubmed: 17365659
J Hypertens. 2009 Dec;27(12):2386-93
pubmed: 19680136
Ophthalmology. 1991 May;98(5 Suppl):786-806
pubmed: 2062513
Atherosclerosis. 2011 Jun;216(2):433-9
pubmed: 21392768
Ophthalmology. 2013 Jan;120(1):91-9
pubmed: 22980743
PLoS One. 2014 Sep 04;9(9):e106551
pubmed: 25188273
JAMA Ophthalmol. 2015 Aug;133(8):947-50
pubmed: 25997175
Am J Ophthalmol. 2015 Dec;160(6):1259-1268.e2
pubmed: 26386158
Retina. 2015 Nov;35(11):2353-63
pubmed: 26465617
Retina. 2015 Nov;35(11):2347-52
pubmed: 26469532
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT362-70
pubmed: 27409494
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT504-10
pubmed: 27454659
Retin Cases Brief Rep. 2017 Winter;11 Suppl 1:S90-S93
pubmed: 27668500
JAMA Ophthalmol. 2017 Apr 1;135(4):306-312
pubmed: 28208170
Am J Ophthalmol. 2017 May;177:131-138
pubmed: 28237415
Prog Retin Eye Res. 2017 Sep;60:66-100
pubmed: 28760677
Am J Ophthalmol. 2017 Oct;182:168-179
pubmed: 28837791
Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4889-4897
pubmed: 28973335
Invest Ophthalmol Vis Sci. 2017 Nov 1;58(13):5754-5763
pubmed: 29114842
Prog Retin Eye Res. 2018 May;64:1-55
pubmed: 29229445
Am J Ophthalmol. 2018 May;189:55-64
pubmed: 29470970
Br J Ophthalmol. 2019 Feb;103(2):216-221
pubmed: 29706601
Graefes Arch Clin Exp Ophthalmol. 2018 Jul;256(7):1275-1280
pubmed: 29713816
Invest Ophthalmol Vis Sci. 2018 Apr 1;59(5):2167-2176
pubmed: 29801151
Am J Ophthalmol. 2018 Aug;192:146-156
pubmed: 29806991
Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):4953-4962
pubmed: 30326063
JAMA Ophthalmol. 2018 Nov 1;136(11):1262-1270
pubmed: 30352115
Invest Ophthalmol Vis Sci. 2018 Dec 3;59(15):5847-5853
pubmed: 30535425
Am J Med Sci. 1974 Dec;268(6):336-45
pubmed: 4616627
Arch Ophthalmol. 1994 Jan;112(1):92-8
pubmed: 8285901